MAOB and Parkinson disease: This is the first longitudinal study to demonstrate that the MAOB rs1799836 polymorphism predicts the development of LID in PD, with a lower risk observed in patients carrying the MAOBCC/(C)/CT genotype (associated with low/intermediate brain enzyme activity).